BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2546266)

  • 1. Characterization of human ovarian cancer lines with a panel of monoclonal antibodies (MoAbs).
    Molthoff CF; Boven E; Calame JJ; van Beek PJ; Pinedo HM
    Strahlenther Onkol; 1989 Jul; 165(7):494-5. PubMed ID: 2546266
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
    Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line.
    Baumal R; Law J; Buick RN; Kahn H; Yeger H; Sheldon K; Colgan T; Marks A
    Cancer Res; 1986 Aug; 46(8):3994-4000. PubMed ID: 3731068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human ovarian cancer xenografts in nude mice: characterization and analysis of antigen expression.
    Molthoff CF; Calame JJ; Pinedo HM; Boven E
    Int J Cancer; 1991 Jan; 47(1):72-9. PubMed ID: 1985883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
    Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
    Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies.
    Miotti S; Aguanno S; Canevari S; Diotti A; Orlandi R; Sonnino S; Colnaghi MI
    Cancer Res; 1985 Feb; 45(2):826-32. PubMed ID: 2981614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental model for radioimmunotherapy of human ovarian carcinoma with I-131-labeled monoclonal antibody OC 125.
    Senekowitsch R; Schmid P; Möllenstädt S; Kriegel H; Pabst HW
    Strahlenther Onkol; 1989 Jul; 165(7):564-6. PubMed ID: 2749501
    [No Abstract]   [Full Text] [Related]  

  • 12. [Can monoclonal antibodies to a carcinoma-specific cell surface molecule prevent liver metastasis of human colorectal carcinoma and effectively treat already existing micrometastases?].
    Burkart C; Porschen R
    Z Gastroenterol; 1996 Jan; 34(1):41-2. PubMed ID: 8776175
    [No Abstract]   [Full Text] [Related]  

  • 13. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors].
    Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K
    Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody against human ovarian tumor-associated antigens.
    Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
    J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
    Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
    Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
    Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.
    Nauta MM; Boven E; Schlüper HM; Erkelens CA; Pinedo HM
    Br J Cancer; 1986 Aug; 54(2):331-5. PubMed ID: 3017398
    [No Abstract]   [Full Text] [Related]  

  • 20. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
    Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
    Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.